ProQR(PRQR) - 2023 Q4 - Annual Report

Exhibit 99.1 ProQR Announces Year End 2023 Operating and Financial Results LEIDEN, Netherlands & CAMBRIDGE, Mass., March 13, 2024 – ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer RNA editing technology platform, today reported its financial and operating results for the year ended December 31, 2023, and provided a business update. "Over the past year as we exclusively focused our strategy on RNA editi ...